Sergio Coffa

Array ( [id] => 7568217 [patent_doc_number] => 20110288280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'COELENTERAMIDE ANALOGS' [patent_app_type] => utility [patent_app_number] => 13/146710 [patent_app_country] => US [patent_app_date] => 2010-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22351 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20110288280.pdf [firstpage_image] =>[orig_patent_app_number] => 13146710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7587282 [patent_doc_number] => 20110281792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'BINDING-SITE MODIFIED LECTINS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/145528 [patent_app_country] => US [patent_app_date] => 2010-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 64438 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281792.pdf [firstpage_image] =>[orig_patent_app_number] => 13145528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9957966 [patent_doc_number] => 09006170 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-14 [patent_title] => 'Compositions for elastogenesis and connective tissue treatment' [patent_app_type] => utility [patent_app_number] => 12/686330 [patent_app_country] => US [patent_app_date] => 2010-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16401 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12686330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7720814 [patent_doc_number] => 20120010149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'PEPTIDE COMBINATION' [patent_app_type] => utility [patent_app_number] => 13/142931 [patent_app_country] => US [patent_app_date] => 2009-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4998 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20120010149.pdf [firstpage_image] =>[orig_patent_app_number] => 13142931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670052 [patent_doc_number] => 20110319321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'MAMMALIAN COLOSTRUM DERIVED NANOPEPTIDES FOR BROADSPECTRUM VIRAL AND RECURRENT INFECTIONS WITH A METHOD OF ISOLATION THEREOF' [patent_app_type] => utility [patent_app_number] => 13/142327 [patent_app_country] => US [patent_app_date] => 2009-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4237 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13142327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8920953 [patent_doc_number] => 08486885 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-16 [patent_title] => 'β-arrestin effectors and compositions and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/647810 [patent_app_country] => US [patent_app_date] => 2009-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19611 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12647810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9020421 [patent_doc_number] => 08530406 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-10 [patent_title] => 'HMG-CoA reductase derived peptide and cosmetic or pharmaceutical composition containing same' [patent_app_type] => utility [patent_app_number] => 13/141123 [patent_app_country] => US [patent_app_date] => 2009-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6379 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13141123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6443612 [patent_doc_number] => 20100144597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Novel combinatorial approaches to enhancing oxygen transport to tissues' [patent_app_type] => utility [patent_app_number] => 12/653343 [patent_app_country] => US [patent_app_date] => 2009-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5230 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144597.pdf [firstpage_image] =>[orig_patent_app_number] => 12653343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8063731 [patent_doc_number] => 20110245156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'NOVEL ANTIVIRAL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/133492 [patent_app_country] => US [patent_app_date] => 2009-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17677 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245156.pdf [firstpage_image] =>[orig_patent_app_number] => 13133492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7756653 [patent_doc_number] => 20120028881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'METHODS AND REAGENTS FOR DIAGNOSING ATHEROMA' [patent_app_type] => utility [patent_app_number] => 13/132828 [patent_app_country] => US [patent_app_date] => 2009-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 16603 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20120028881.pdf [firstpage_image] =>[orig_patent_app_number] => 13132828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7696170 [patent_doc_number] => 20110230420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'RELEASABLE CONJUGATES FOR NUCLEIC ACIDS DELIVERY SYSTEMS' [patent_app_type] => utility [patent_app_number] => 13/129705 [patent_app_country] => US [patent_app_date] => 2009-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 25724 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0230/20110230420.pdf [firstpage_image] =>[orig_patent_app_number] => 13129705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561722 [patent_doc_number] => 20110275555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'COMPOSITIONS CONTAINING DELTA-9-THC-AMINO ACID ESTERS AND PROCESS OF PREPARATION' [patent_app_type] => utility [patent_app_number] => 13/126606 [patent_app_country] => US [patent_app_date] => 2009-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 6996 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275555.pdf [firstpage_image] =>[orig_patent_app_number] => 13126606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574012 [patent_doc_number] => 20110269668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'Fused Heteroaryl Diamide Compounds Useful as MMP-13 Inhibitors' [patent_app_type] => utility [patent_app_number] => 13/123002 [patent_app_country] => US [patent_app_date] => 2009-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7321 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269668.pdf [firstpage_image] =>[orig_patent_app_number] => 13123002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511372 [patent_doc_number] => 20110257082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'HIV-1 INTEGRASE DERIVED STIMULATORY PEPTIDES INTERFERING WITH INTEGRASE -- REV PROTEIN BINDING' [patent_app_type] => utility [patent_app_number] => 13/122548 [patent_app_country] => US [patent_app_date] => 2009-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12426 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257082.pdf [firstpage_image] =>[orig_patent_app_number] => 13122548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6101620 [patent_doc_number] => 20110165112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'POLYMER CONJUGATES OF C-PEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/119217 [patent_app_country] => US [patent_app_date] => 2009-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 30984 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165112.pdf [firstpage_image] =>[orig_patent_app_number] => 13119217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6101621 [patent_doc_number] => 20110165113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'POLYMER CONJUGATES OF V681-LIKE PEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/119236 [patent_app_country] => US [patent_app_date] => 2009-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 30986 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165113.pdf [firstpage_image] =>[orig_patent_app_number] => 13119236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6187665 [patent_doc_number] => 20110171161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'POLYMER CONJUGATES OF PROTEGRIN PEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/119216 [patent_app_country] => US [patent_app_date] => 2009-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 34587 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171161.pdf [firstpage_image] =>[orig_patent_app_number] => 13119216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6187672 [patent_doc_number] => 20110171164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'POLYMER CONJUGATES OF GLP-2-LIKE PEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/119240 [patent_app_country] => US [patent_app_date] => 2009-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27848 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171164.pdf [firstpage_image] =>[orig_patent_app_number] => 13119240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6046531 [patent_doc_number] => 20110206633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'POLYMER CONJUGATES OF CD-NP PEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/119219 [patent_app_country] => US [patent_app_date] => 2009-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 33228 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20110206633.pdf [firstpage_image] =>[orig_patent_app_number] => 13119219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6187674 [patent_doc_number] => 20110171166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'POLYMER CONJUGATES OF OSTEOCALCIN PEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/119301 [patent_app_country] => US [patent_app_date] => 2009-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27041 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171166.pdf [firstpage_image] =>[orig_patent_app_number] => 13119301 [rel_patent_id] =>[rel_patent_doc_number] =>)